Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAL: Doxycycline in AL Amyloidosis
NCT02207556Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in amyloid light chain amyloidosis, sponsored by Medical College of Wisconsin. Started Oct 2014; status: completed.
02
Drugs
doxycycline
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT02207556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02207556.